Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Biological
Study Type: Observational
SUMMARY

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by a peripheral destruction of platelets responsible for bleedings. Monocytes/macrophages play a double role by phagocyting platelets recognized by autoantibodies and by maintaining the autoimmune response via their antigen-presenting cell functions. Fcgamma receptors (FcγR), that are represented by activating receptors (FcγRI, FcγRIIa, FcγRIII) and an inhibiting one (FcγRIIb), are involved in the regulation of macrophages and have been reported to be dysregulated in autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematous. The aim of this study is to compare the expression of FcγR in patients with ITP on circulating monocytes and on splenic macrophages.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ ITP group

• Patients who have provided written consent

• Patients over 18 years

• Patients with national health insurance

• Patients with ITP, defined as thrombocytopenia \< 100 G/L, after exclusion of infection- or drug-related thrombocytopenia and malignant hemopathy.

⁃ Control Group

• Persons who have provided a written consent

• Persons over 18 years

• Persons with national health insurance

• Persons without autoimmune disease

Locations
Other Locations
France
CHU Dijon Bourgogne
RECRUITING
Dijon
Contact Information
Primary
Bernard BONNOTTE
bernard.bonnotte@chu-dijon.fr
3.80.29.34.32
Time Frame
Start Date: 2014-10-02
Estimated Completion Date: 2024-09
Participants
Target number of participants: 70
Treatments
patient
control
Sponsors
Leads: Centre Hospitalier Universitaire Dijon

This content was sourced from clinicaltrials.gov